LINCS MCF 10A Common Project: Rolling-time-point sensitivity measures of the MCF 10A breast cell line to 8 small molecule perturbagens. Dataset 1 of 15: End-point cell counts and normalized growth rate inhibition values for all technical replicates of biological replicate 1. - Dataset (ID:20309)
Download: Excel (XLSX), Comma-separated (CSV)
| Cell | Small Molecule | Small Mol Concentration (uM) | Time Point (hr) | Total Cell Count Before Treatment | Total Cell Count After Treatment | Total Control Cell Count | Relative Cell Count | Normalized Growth Rate Inhibition Value | Assay Plate | Assay Well |
|---|---|---|---|---|---|---|---|---|---|---|
| MCF 10A-H2B-mCherry | Neratinib | 0.0053333 | 83.42 | 770.25 | 12428 | 12031 | 1.0329 | 1.0164 | MN20160304_L02 | I21 |
| MCF 10A-H2B-mCherry | Neratinib | 0.0053333 | 85.64 | 770.25 | 13104 | 12287 | 1.0665 | 1.0325 | MN20160304_L02 | D17 |
| MCF 10A-H2B-mCherry | Neratinib | 0.0053333 | 85.64 | 770.25 | 12783 | 12287 | 1.0403 | 1.0199 | MN20160304_L02 | I21 |
| MCF 10A-H2B-mCherry | Neratinib | 0.0053333 | 87.86 | 770.25 | 13586 | 12543 | 1.0831 | 1.0401 | MN20160304_L02 | D17 |
| MCF 10A-H2B-mCherry | Neratinib | 0.0053333 | 87.86 | 770.25 | 13016 | 12543 | 1.0377 | 1.0185 | MN20160304_L02 | I21 |
| MCF 10A-H2B-mCherry | Neratinib | 0.01 | 3.21 | 770.25 | 978 | 904 | 1.0811 | 1.7991 | MN20160304_L02 | D22 |
| MCF 10A-H2B-mCherry | Neratinib | 0.01 | 3.21 | 770.25 | 902 | 904 | 0.9971 | 0.9751 | MN20160304_L02 | I04 |
| MCF 10A-H2B-mCherry | Neratinib | 0.01 | 5.44 | 770.25 | 1063 | 1012 | 1.0496 | 1.2609 | MN20160304_L02 | D22 |
| MCF 10A-H2B-mCherry | Neratinib | 0.01 | 5.44 | 770.25 | 1008 | 1012 | 0.9953 | 0.9763 | MN20160304_L02 | I04 |
| MCF 10A-H2B-mCherry | Neratinib | 0.01 | 7.66 | 770.25 | 1194 | 1090 | 1.0954 | 1.3990 | MN20160304_L02 | D22 |
| MCF 10A-H2B-mCherry | Neratinib | 0.01 | 7.66 | 770.25 | 1081 | 1090 | 0.9917 | 0.9672 | MN20160304_L02 | I04 |
| MCF 10A-H2B-mCherry | Neratinib | 0.01 | 10.06 | 770.25 | 1296 | 1218 | 1.0636 | 1.1953 | MN20160304_L02 | D22 |
| MCF 10A-H2B-mCherry | Neratinib | 0.01 | 10.06 | 770.25 | 1198 | 1218 | 0.9832 | 0.9494 | MN20160304_L02 | I04 |
| MCF 10A-H2B-mCherry | Neratinib | 0.01 | 12.28 | 770.25 | 1413 | 1358 | 1.0404 | 1.0992 | MN20160304_L02 | D22 |
| MCF 10A-H2B-mCherry | Neratinib | 0.01 | 12.28 | 770.25 | 1372 | 1358 | 1.0102 | 1.0250 | MN20160304_L02 | I04 |
| MCF 10A-H2B-mCherry | Neratinib | 0.01 | 14.50 | 770.25 | 1580 | 1497 | 1.0553 | 1.1154 | MN20160304_L02 | D22 |
| MCF 10A-H2B-mCherry | Neratinib | 0.01 | 14.50 | 770.25 | 1564 | 1497 | 1.0446 | 1.0931 | MN20160304_L02 | I04 |
| MCF 10A-H2B-mCherry | Neratinib | 0.01 | 16.73 | 770.25 | 1697 | 1664 | 1.0195 | 1.0351 | MN20160304_L02 | D22 |
| MCF 10A-H2B-mCherry | Neratinib | 0.01 | 16.73 | 770.25 | 1753 | 1664 | 1.0532 | 1.0954 | MN20160304_L02 | I04 |
| MCF 10A-H2B-mCherry | Neratinib | 0.01 | 18.95 | 770.25 | 1803 | 1832 | 0.9839 | 0.9742 | MN20160304_L02 | D22 |
| MCF 10A-H2B-mCherry | Neratinib | 0.01 | 18.95 | 770.25 | 1872 | 1832 | 1.0216 | 1.0344 | MN20160304_L02 | I04 |
| MCF 10A-H2B-mCherry | Neratinib | 0.01 | 21.17 | 770.25 | 1989 | 2008 | 0.9904 | 0.9860 | MN20160304_L02 | D22 |
| MCF 10A-H2B-mCherry | Neratinib | 0.01 | 21.17 | 770.25 | 2013 | 2008 | 1.0023 | 1.0033 | MN20160304_L02 | I04 |
| MCF 10A-H2B-mCherry | Neratinib | 0.01 | 23.39 | 770.25 | 2224 | 2244 | 0.9909 | 0.9881 | MN20160304_L02 | D22 |
| MCF 10A-H2B-mCherry | Neratinib | 0.01 | 23.39 | 770.25 | 2186 | 2244 | 0.9739 | 0.9661 | MN20160304_L02 | I04 |